Masimo Co. (MASI) COO Anand Sampath Sells 30,000 Shares

Masimo Co. (NASDAQ:MASI) COO Anand Sampath sold 30,000 shares of the stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $110.00, for a total transaction of $3,300,000.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Masimo stock traded up $0.96 during midday trading on Friday, hitting $110.42. 463,404 shares of the company’s stock were exchanged, compared to its average volume of 499,700. Masimo Co. has a 12 month low of $80.69 and a 12 month high of $126.89. The stock has a market cap of $5.80 billion, a price-to-earnings ratio of 45.07, a PEG ratio of 2.41 and a beta of 1.11.

Masimo (NASDAQ:MASI) last issued its earnings results on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.02. Masimo had a net margin of 17.08% and a return on equity of 20.29%. The company had revenue of $210.58 million for the quarter, compared to analysts’ expectations of $207.62 million. During the same period in the prior year, the business earned $0.56 EPS. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. Research analysts predict that Masimo Co. will post 2.92 earnings per share for the current year.

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its holdings in shares of Masimo by 23.1% in the 3rd quarter. BlackRock Inc. now owns 8,311,900 shares of the medical equipment provider’s stock valued at $1,035,164,000 after buying an additional 1,562,019 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Masimo by 2.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,147,708 shares of the medical equipment provider’s stock valued at $516,556,000 after buying an additional 109,065 shares in the last quarter. FMR LLC boosted its holdings in shares of Masimo by 81.2% in the 3rd quarter. FMR LLC now owns 3,301,975 shares of the medical equipment provider’s stock valued at $411,229,000 after buying an additional 1,479,981 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Masimo by 932.6% in the 3rd quarter. American Century Companies Inc. now owns 850,436 shares of the medical equipment provider’s stock valued at $105,913,000 after buying an additional 768,078 shares in the last quarter. Finally, Schroder Investment Management Group boosted its holdings in shares of Masimo by 77.2% in the 2nd quarter. Schroder Investment Management Group now owns 799,435 shares of the medical equipment provider’s stock valued at $106,225,000 after buying an additional 348,169 shares in the last quarter. Institutional investors and hedge funds own 88.00% of the company’s stock.

MASI has been the topic of several recent research reports. Stifel Nicolaus increased their target price on shares of Masimo from $112.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 2nd. BidaskClub cut shares of Masimo from a “buy” rating to a “hold” rating in a report on Tuesday, November 13th. Zacks Investment Research cut shares of Masimo from a “buy” rating to a “hold” rating in a report on Tuesday. Piper Jaffray Companies increased their target price on shares of Masimo to $120.00 and gave the stock a “neutral” rating in a report on Thursday, November 1st. Finally, UBS Group initiated coverage on shares of Masimo in a report on Tuesday. They set a “buy” rating and a $137.00 target price on the stock. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $119.00.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.com-unik.info/2018/12/01/masimo-co-masi-coo-anand-sampath-sells-30000-shares.html.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Story: Understanding each part of a balance sheet

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit